In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis
Anna F. Fajardo, Chethana P. Gowda, Emily Johnson, Ricardo Petroni, Vivek S. Tomar, Zhenqiu Liu, M. Andres Blanco, Jacob Janssen, Irina A. Elcheva, Matthew Lanza, Serge Y. Fuchs, Vladimir S. Spiegelman · 2026
Read In vivo CRISPR knockout screen identifies Polr1a as a key driver and a potential therapeutic target for melanoma metastasis by Anna F. Fajardo, Chethana P. Gowda, Emily Johnson, Ricardo Petroni, Vivek S. Tomar, Zhenqiu Liu, M. Andres Blanco, Jacob Janssen, Irina A. Elcheva, Matthew Lanza, Serge Y. Fuchs, Vladimir S. Spiegelman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13364679.txt.
Description
Anna Fajardo and co-workers hunt in 2026 for genes that drive the spread of melanoma, a harsh skin cancer. They knock out suspect genes in live mice with a gene edit screen and watch which loss stops spread. One gene, Polr1a, stood out as a strong driver.
High ranks of the gene in patients track with more spread and short life. Blocking it cut cell move, lung spread, and tumor growth in tests. Its pull runs through a cell growth path that drug care can hit. The team sees Polr1a blocks as a pre surgery care path worth trials.
Catalog record
| CREATOR | Anna F. Fajardo, Chethana P. Gowda, Emily Johnson, Ricardo Petroni, Vivek S. Tomar, Zhenqiu Liu, M. Andres Blanco, Jacob Janssen, Irina A. Elcheva, Matthew Lanza, Serge Y. Fuchs, Vladimir S. Spiegelman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45502 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |